Effect of a collagen membrane enriched with fibronectin on guided tissue regeneration in dogs.
The present study was planned to assess the capacity of a resorbable collagen membrane enriched with fibronectin to prevent the apical migration of epithelium and to facilitate new attachment and new bone. Experimental osseous dehiscence defects were produced on the bilateral labial aspect of mandibular 2nd, 3rd and 4th premolar teeth in six mongrel dogs. Guided tissue regeneration therapy using collagen membranes, which were rehydrated with fibronectin solution, was performed on one quadrant (group A). In the contralateral quadrant, the same collagen membranes, but rehydrated only with saline (group B), were placed over the bony defects. The third premolar teeth, which were treated by open-flap debridement, served as control (group C). Flaps were positioned slightly coronally and sutured; sutures were removed 10 days later. The dogs were killed 30 days after reconstructive therapy. Tissue blocks containing the experimental and control teeth were excised, demineralized in EDTA, and embedded in paraffin. Histological and histometric evaluation revealed that all groups demonstrated similar effects on preventing the down-growth of epithelium and formation of new cementum and new bone. Collagen membranes were tolerated well within the tissues, and membrane remnants were identified at 30 days. In summary, this study indicated that in this dog model similar healing results could be achieved with a bovine type I collagen membrane with or without fibronectin solution and open-flap debridement.
Kurtis
Bülent
B
Department of Periodontology, Faculty of Dentistry, University of Gazi, Ankara, Turkey.
Balos
Köksal
K
Oygür
Tülin
T
D020341:Absorbable Implants; D016301:Alveolar Bone Loss / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D000539:Alveolar Process / Q000187:drug effects / Q000473:pathology; D000818:Animals; D002417:Cattle; D025021:Cementogenesis / Q000187:drug effects; D024042:Collagen Type I; D003646:Debridement; D003739:Dental Cementum / Q000187:drug effects / Q000473:pathology; D004285:Dogs; D004848:Epithelium / Q000187:drug effects / Q000473:pathology; D005353:Fibronectins / Q000627:therapeutic use*; D016557:Guided Tissue Regeneration, Periodontal / Q000295:instrumentation*; D016555:Matched-Pair Analysis; D008567:Membranes, Artificial; D010012:Osteogenesis / Q000187:drug effects; D017622:Periodontal Attachment Loss / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D012965:Sodium Chloride; D013223:Statistics as Topic; D013524:Surgical Flaps
D024042:Collagen Type I; D005353:Fibronectins; D008567:Membranes, Artificial; D012965:Sodium Chloride